Qureshi Haneya Naeem, Manalastas Marvin, Zaidi Syed Muhammad Asad, Imran Ali, Al Kalaa Mohamad Omar
Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
School of Electrical and Computer Engineering, The University of Oklahoma-Tulsa, Tulsa, OK 74135, USA.
IEEE Access. 2021 Jan 5;9:1044-1061. doi: 10.1109/access.2020.3046927.
5G and beyond networks will transform the healthcare sector by opening possibilities for novel use cases and applications. Service level agreements (SLAs) can enable 5G-enabled medical device use cases by documenting how a medical device communication requirements are met by the unique characteristics of 5G networks and the roles and responsibilities of the stakeholders involved in offering safe and effective 5G-enabled healthcare to patients. However, there are gaps in this space that should be addressed to facilitate the efficient implementation of 5G technology in healthcare. Current literature is scarce regarding SLAs for 5G and is absent regarding SLAs for 5G-enabled medical devices. This paper aims to bridge these gaps by identifying key challenges, providing insight, and describing open research questions related to SLAs in 5G and specifically 5G-healthcare systems. This is helpful to network service providers, users, and regulatory authorities in developing, managing, monitoring, and evaluating SLAs in 5G-enabled medical systems.
5G及未来网络将通过为新型用例和应用开辟可能性来变革医疗保健行业。服务水平协议（SLA）可以通过记录5G网络的独特特性如何满足医疗设备通信要求以及参与为患者提供安全有效的5G医疗保健的利益相关者的角色和责任，来实现支持5G的医疗设备用例。然而，这一领域存在一些差距，需要加以解决，以促进5G技术在医疗保健领域的高效实施。目前关于5G的SLA的文献很少，关于支持5G的医疗设备的SLA的文献则完全没有。本文旨在通过识别关键挑战、提供见解并描述与5G特别是5G医疗保健系统中的SLA相关的开放研究问题来弥合这些差距。这有助于网络服务提供商、用户和监管机构在支持5G的医疗系统中开发、管理、监控和评估SLA。
